Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment

References

• DefronzoRABanting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusDiabetes2009584773 79519336687
   PubMed Web of Science ®Google Scholar
• StrattonIMAdlerAINeilHAAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ20003217258405 41210938048
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2013Diabetes Care201336Suppl 1S11 S6623264422
   PubMed Web of Science ®Google Scholar
• GarberAJAbrahamsonMJBarzilayJIAmerican Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement – executive summaryEndocr Pract2013193536 55723816937
   PubMed Web of Science ®Google Scholar
• InzucchiSEBergenstalRMBuseJBAmerican Diabetes Association (ADA)European Association for the Study of Diabetes (EASD)Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care20123561364 137922517736
   PubMed Web of Science ®Google Scholar
• CookMNGirmanCJSteinPPAlexanderCMInitial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with type 2 diabetes in UK primary careDiabet Med2007244350 35817335466
   PubMed Web of Science ®Google Scholar
• CookeCELeeHYTongYPHainesSTPersistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organizationCurr Med Res Opin2010261231 23819921965
   PubMed Web of Science ®Google Scholar
• RubinRRPeyrotMKrugerDFTravisLBBarriers to insulin injection therapy: patient and health care provider perspectivesDiabetes Educ20093561014 102219934459
   PubMed Web of Science ®Google Scholar
• NakarSYitzhakiGRosenbergRVinkerSTransition to insulin in type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriersJ Diabetes Complications2007214220 22617616351
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRLauritzenTInternational DAWN Advisory PanelResistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) studyDiabetes Care200528112673 267916249538
   PubMed Web of Science ®Google Scholar
• PolonskyWHFisherLGuzmanSVilla-CaballeroLEdelmanSVPsychological insulin resistance in patients with type 2 diabetes: the scope of the problemDiabetes Care200528102543 254516186296
   PubMed Web of Science ®Google Scholar
• RatanawongsaNCrossonJCSchillingerDKarterAJSahaCKMarreroDGGetting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts ProjectDiabetes Educ201238194 10022222513
   PubMed Web of Science ®Google Scholar
• TanAMMuthusamyLNgCCPhoonKYOwJHTanNCInitiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative studySingapore Med J20115211801 80922173249
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRLauritzenTSnoekFJMatthewsDRSkovlundSEPsychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) StudyDiabet Med200522101379 138516176200
   PubMed Web of Science ®Google Scholar
• HoltRINicolucciAKovacs BurnsKDAWN2 Study GroupDiabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care – healthcare professional perspectiveDiabet Med2013307789 79823710839
   PubMed Web of Science ®Google Scholar
• FunnellMMOvercoming barriers to the initiation of insulin therapyClin Diabetes200725136 38
   Google Scholar
• AliSStoneMAPetersJLDaviesMJKhuntiKThe prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysisDiabet Med200623111165 117317054590
   PubMed Web of Science ®Google Scholar
• AndersonRJFreedlandKEClouseRELustmanPJThe prevalence of comorbid depression in adults with diabetes: a meta-analysisDiabetes Care20012461069 107811375373
   PubMed Web of Science ®Google Scholar
• GonzalezJSPeyrotMMcCarlLADepression and diabetes treatment nonadherence: a meta-analysisDiabetes Care200831122398 240319033420
   PubMed Web of Science ®Google Scholar
• LustmanPJAndersonRJFreedlandKEde GrootMCarneyRMClouseREDepression and poor glycemic control: a meta-analytic review of the literatureDiabetes Care2000237934 94210895843
   PubMed Web of Science ®Google Scholar
• MakineCKarşidağCKadioğluPSymptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research ConsortiumDiabet Med200926128 3319125757
   PubMed Web of Science ®Google Scholar
• KarterAJSubramanianUSahaCBarriers to insulin initiation: the translating research into action for diabetes insulin starts projectDiabetes Care2010334733 73520086256
   PubMed Web of Science ®Google Scholar
• FeitosaACSampaioLNBatistaAGPinheiroCBFrequency of fear of needles and impact of a multidisciplinary educational approach towards pregnant women with diabetesRev Bras Ginecol Obstet2013353111 11623538469
   PubMedGoogle Scholar
• FuAZQiuYRadicanLImpact of fear of insulin or fear of injection on treatment outcomes of patients with diabetesCurr Med Res Opin20092561413 142019422281
   PubMed Web of Science ®Google Scholar
• GillHSPrausnitzMRDoes needle size matter?J Diabetes Sci Technol200715725 72919885141
   PubMedGoogle Scholar
• IgnautDAFuHComparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitusJ Diabetes Sci Technol201262389 39322538152
   PubMedGoogle Scholar
• KreugelGKeersJCKerstensMNWolffenbuttelBHRandomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetesDiabetes Technol Ther2011137737 74121476936
   PubMed Web of Science ®Google Scholar
• Arendt-NielsenLEgekvistHBjerringPPain following controlled cutaneous insertion of needles with different diametersSomatosens Mot Res2006231–237 4316846958
   PubMed Web of Science ®Google Scholar
• SchwartzSHassmanDShelmetJA multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6 mm needle versus a 29 gauge × 12.7 mm needle in obese patients with diabetes mellitusClin Ther200426101663 167815598483
   PubMed Web of Science ®Google Scholar
• CoghillRCGracelyRHValidation of combined numerical-analog descriptor scales for rating pain intensity and pain unpleasantness 15th Scientific Meeting of the American Pain Society November 14–17, 1996 Washington, DC
   Google Scholar
• SiegmundTBlankenfeldHSchumm-DraegerPMComparison of usability and patient preference for insulin pen needles produced with different production techniques: “thin-wall” needles compared to “regular-wall” needles: an open-label studyDiabetes Technol Ther2009118523 52819698066
   PubMed Web of Science ®Google Scholar
• NagaiYOhshigeTAraiKComparison between shorter straight and thinner microtapered insulin injection needlesDiabetes Technol Ther2013157550 55523621793
   PubMed Web of Science ®Google Scholar
• ChantelauELeeDMHemmannDMZipfelUEchterhoffSWhat makes insulin injections painful?BMJ1991303679326 271859951
   PubMed Web of Science ®Google Scholar
• HirschLGibneyMBerubeJManocchioJImpact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetesJ Diabetes Sci Technol201262328 33522538142
   PubMedGoogle Scholar
• MollemaEDSnoekFJHeineRJvan der PloegHMPhobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screeningDiabet Med2001188671 67411553207
   PubMed Web of Science ®Google Scholar
• FunnellMMKrugerDFSpencerMSelf-management support for insulin therapy in type 2 diabetesDiabetes Educ2004302274 28015095517
   PubMed Web of Science ®Google Scholar
• WelchGZagarinsSEFeinbergRGGarbJLMotivational interviewing delivered by diabetes educators: does it improve blood glucose control among poorly controlled type 2 diabetes patients?Diabetes Res Clin Pract201191154 6021074887
   PubMed Web of Science ®Google Scholar
• IwanagaMKamoiKPatient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needlesDiabetes Technol Ther200911281 8619848573
   PubMed Web of Science ®Google Scholar
• PhillipsPType 2 diabetes – failure, blame and guilt in the adoption of insulin therapyRev Diabet Stud20052135 3917491657
   PubMedGoogle Scholar
• SiminerioLKulkarniKMeeceJStrategies for Insulin Injection Therapy in Diabetes Self-ManagementChicago, ILAmerican Association of Diabetes Education2011 Available from: http://www.diabeteseducator.org/export/sites/aade/_resources/pdf/research/aade_meded.pdfAccessed July 14, 2014
   Google Scholar
• American Diabetes AssociationInsulin administrationDiabetes Care200427Suppl 1S106 S10914693942
   PubMedGoogle Scholar
• HofmanPLDerraikJGPintoTEDefining the ideal injection techniques when using 5-mm needles in children and adultsDiabetes Care20103391940 194420585002
   PubMed Web of Science ®Google Scholar
• RzeszutJRChildren with diabetes: the impact of fear of needlesJ Pediatr Nurs2011266589 59221925589
   PubMed Web of Science ®Google Scholar
• SparksLTaking the “ouch” out of injections for children. Using distraction to decrease painMCN Am J Matern Child Nurs200126272 7811265439
   PubMedGoogle Scholar
• UmanLSChambersCTMcGrathPJKiselySA systematic review of randomized controlled trials examining psychological interventions for needle-related procedural pain and distress in children and adolescents: an abbreviated Cochrane reviewJ Pediatr Psychol2008338842 85418387963
   PubMed Web of Science ®Google Scholar
• HauberABJohnsonFRSauriolLLescrauwaetBRisking health to avoid injections: preferences of Canadians with type 2 diabetesDiabetes Care20052892243 224516123499
   PubMed Web of Science ®Google Scholar
• HauberABHanSYangJCEffect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetesPatient Prefer Adherence20137937 94924086104
   PubMed Web of Science ®Google Scholar
• BaeJPDobeshPPKlepserDGAdherence and dosing frequency of common medications for cardiovascular patientsAm J Manag Care2012183139 14622435907
   PubMed Web of Science ®Google Scholar
• García-PérezLEAlvarezMDillaTGil-GuillénVOrozco-BeltránDAdherence to therapies in patients with type 2 diabetesDiabetes Ther201342175 19423990497
   PubMed Web of Science ®Google Scholar
• SrivastavaKAroraAKatariaACappelleriJCSadoskyAPetersonAMImpact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysisPatient Prefer Adherence20137419 43423737662
   PubMed Web of Science ®Google Scholar
• HauberABNguyenHPosnerJErvinCLaRueSKalsekarIPatient preferences for frequency of glucagon-like peptide-1 receptor agonist (GLP-1RA) injections in the treatment of type 2 diabetes. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting; 2014 May 31–June 4; Montreal, QC, CanadaValue Health2014173A255
   Web of Science ®Google Scholar